1116 related articles for article (PubMed ID: 15866165)
1. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.
Glass DA; Bialek P; Ahn JD; Starbuck M; Patel MS; Clevers H; Taketo MM; Long F; McMahon AP; Lang RA; Karsenty G
Dev Cell; 2005 May; 8(5):751-64. PubMed ID: 15866165
[TBL] [Abstract][Full Text] [Related]
2. Canonical Wnt signaling in osteoblasts is required for osteoclast differentiation.
Glass DA; Karsenty G
Ann N Y Acad Sci; 2006 Apr; 1068():117-30. PubMed ID: 16831912
[TBL] [Abstract][Full Text] [Related]
3. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis.
Day TF; Guo X; Garrett-Beal L; Yang Y
Dev Cell; 2005 May; 8(5):739-50. PubMed ID: 15866164
[TBL] [Abstract][Full Text] [Related]
4. Essential role of beta-catenin in postnatal bone acquisition.
Holmen SL; Zylstra CR; Mukherjee A; Sigler RE; Faugere MC; Bouxsein ML; Deng L; Clemens TL; Williams BO
J Biol Chem; 2005 Jun; 280(22):21162-8. PubMed ID: 15802266
[TBL] [Abstract][Full Text] [Related]
5. EBF2 regulates osteoblast-dependent differentiation of osteoclasts.
Kieslinger M; Folberth S; Dobreva G; Dorn T; Croci L; Erben R; Consalez GG; Grosschedl R
Dev Cell; 2005 Dec; 9(6):757-67. PubMed ID: 16326388
[TBL] [Abstract][Full Text] [Related]
6. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
[TBL] [Abstract][Full Text] [Related]
7. Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro.
Spencer GJ; Utting JC; Etheridge SL; Arnett TR; Genever PG
J Cell Sci; 2006 Apr; 119(Pt 7):1283-96. PubMed ID: 16522681
[TBL] [Abstract][Full Text] [Related]
8. Wnt/beta-catenin--a canonical tale of cell-fate choice in the vertebrate skeleton.
Kolpakova E; Olsen BR
Dev Cell; 2005 May; 8(5):626-7. PubMed ID: 15866155
[TBL] [Abstract][Full Text] [Related]
9. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes.
Hill TP; Später D; Taketo MM; Birchmeier W; Hartmann C
Dev Cell; 2005 May; 8(5):727-38. PubMed ID: 15866163
[TBL] [Abstract][Full Text] [Related]
10. N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation.
Haÿ E; Laplantine E; Geoffroy V; Frain M; Kohler T; Müller R; Marie PJ
Mol Cell Biol; 2009 Feb; 29(4):953-64. PubMed ID: 19075000
[TBL] [Abstract][Full Text] [Related]
11. Sequential roles of Hedgehog and Wnt signaling in osteoblast development.
Hu H; Hilton MJ; Tu X; Yu K; Ornitz DM; Long F
Development; 2005 Jan; 132(1):49-60. PubMed ID: 15576404
[TBL] [Abstract][Full Text] [Related]
12. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
13. Wnt signaling and osteoblastogenesis.
Bodine PV; Komm BS
Rev Endocr Metab Disord; 2006 Jun; 7(1-2):33-9. PubMed ID: 16960757
[TBL] [Abstract][Full Text] [Related]
14. Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation.
Mansukhani A; Ambrosetti D; Holmes G; Cornivelli L; Basilico C
J Cell Biol; 2005 Mar; 168(7):1065-76. PubMed ID: 15781477
[TBL] [Abstract][Full Text] [Related]
15. Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption.
Xiong L; Jung JU; Wu H; Xia WF; Pan JX; Shen C; Mei L; Xiong WC
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3487-92. PubMed ID: 25733894
[TBL] [Abstract][Full Text] [Related]
16. Regulation of bone metabolism by Wnt signals.
Kobayashi Y; Uehara S; Udagawa N; Takahashi N
J Biochem; 2016 Apr; 159(4):387-92. PubMed ID: 26711238
[TBL] [Abstract][Full Text] [Related]
17. Secreted frizzled-related protein 1 modulates glucocorticoid attenuation of osteogenic activities and bone mass.
Wang FS; Lin CL; Chen YJ; Wang CJ; Yang KD; Huang YT; Sun YC; Huang HC
Endocrinology; 2005 May; 146(5):2415-23. PubMed ID: 15677765
[TBL] [Abstract][Full Text] [Related]
18. In vivo analysis of Wnt signaling in bone.
Glass DA; Karsenty G
Endocrinology; 2007 Jun; 148(6):2630-4. PubMed ID: 17395705
[TBL] [Abstract][Full Text] [Related]
19. The orphan receptor tyrosine kinase Ror2 modulates canonical Wnt signaling in osteoblastic cells.
Billiard J; Way DS; Seestaller-Wehr LM; Moran RA; Mangine A; Bodine PV
Mol Endocrinol; 2005 Jan; 19(1):90-101. PubMed ID: 15388793
[TBL] [Abstract][Full Text] [Related]
20. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.
Li J; Sarosi I; Cattley RC; Pretorius J; Asuncion F; Grisanti M; Morony S; Adamu S; Geng Z; Qiu W; Kostenuik P; Lacey DL; Simonet WS; Bolon B; Qian X; Shalhoub V; Ominsky MS; Zhu Ke H; Li X; Richards WG
Bone; 2006 Oct; 39(4):754-66. PubMed ID: 16730481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
